Berry Genes: Announcement on the Wholly-owned Subsidiary Chromosome Copy Number Variation Data Analysis Software Obtaining a Medical Device Registration Certificate
Berry Genomics: Financial Report for the first half of 2024.
Berry Genomics: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Berry Genomics: Announcement on Progress and Completion of Property Rights Transfer for the Sale of Assets by Wholly-owned Subsidiaries.
Berry Genomics: Announcement Regarding Appointment of Secretary of the Board of Directors
Berry Genomics: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Berry Genomics: Legal Opinion of Beijing King & Wood Mallesons on Berry Gene's 2023 Annual General Meeting of Shareholders
Berry Genes: Announcement on Hiring an Audit Institution for 2024
Berry Gene: Announcement on preparation for impairment of assets accrued for 2023
Berry Genomics: 2023 Financial Results Report
Berry Gene: 2023 General Manager Work Report
Berry Gene: Announcement on reducing registered capital and amending the “Articles of Association”
Berry Genes: Internal Control Self-Evaluation Report
Berry Gene: Notice of Annual General Meeting of Shareholders
Berry Genes: Accounting Services Selection and Employment System
Berry Gene: Announcement on the extension of the term of the first employee stock ownership plan
Berry Gene: Announcement on the Judicial Marking of Some Shares of the Controlling Shareholders' Concerted Actors
Berry Gene: Announcement on the Wholly-owned Subsidiary's Chromosome Copy Number Variation Test Kit Obtaining a Medical Device Registration Certificate
Berry Gene: Announcement on the Wholly-owned Subsidiary Obtaining an Invention Patent Certificate
Berry Gene: Announcement on receipt of decisions and warning letters from the Sichuan Securities Regulatory Bureau ordering corrective measures
No Data
No Data